PRF1 and cancer: Recent studies using RNA sequencing in human cancers have reported cytotoxic characteristics of CD4+ T cells, which express cytolytic molecules such as granzymes, perforin, and granulysin in the tumors and circulation of cancer patients [38,39,40,41].